Internal Server Error

Reshape Biotech - About the company

Reshape Biotech is a series A company based in Kongens Lyngby (Denmark), founded in 2018 by Magnus Madsen, Carl-Emil Grøn and Daniel Storgaard. It operates as a Provider of scalable robotic platform. Reshape Biotech has raised $29.2M in funding from investors like Y Combinator, ACME and Astanor. The company has 37 active competitors, including 11 funded and 7 that have exited. Its top competitors include companies like Automata, Opentrons and Transcriptic.

Company Details

Provider of scalable robotic platform. It provides automated imaging and incubation capabilities, designed for data-driven decision making in microbiology research and development labs. Its also designed to simplify routine tasks, freeing up scientists to focus on more complex research and collaboration.
Email ID
*****@reshapebiotech.com
Phone Number
+45 **********
Key Metrics
Founded Year
2018
Location
Kongens Lyngby, Denmark
Stage
Series A
Total Funding
$29.2M in 4 rounds
Latest Funding Round
Ranked
Employee Count
64 as on May 31, 2026
Similar Companies
Sign up to download Reshape Biotech's company profile

Reshape Biotech's funding and investors

Reshape Biotech has raised a total funding of $29.2M over 4 rounds. Its first funding round was on 2021. Its latest funding round was a Series A round on Apr 09, 2024 for $*****. 6 investors participated in its latest round. Reshape Biotech has 8 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Reshape Biotech:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Apr 09, 2024
8050839
Series A
4978302
1967162
6304346
3565243
Feb 09, 2023
9581313
Seed
8493578
1198964
7303588
May 23, 2021
2120068
Seed
2445330
8679622
9890451
lockAccess funding benchmarks and valuations. Sign up today!

Reshape Biotech's founders and board of directors

Founder? Claim Profile
The founders of Reshape Biotech are Magnus Madsen, Carl-Emil Grøn and Daniel Storgaard. Carl-Emil Grøn is the CEO of Reshape Biotech.
Here are the details of Reshape Biotech's key team members:

Reshape Biotech's employee count trend

Reshape Biotech has 64 employees as of May 26. Here is Reshape Biotech's employee count trend over the years:
Employee count trend for Reshape Biotech
lockUncover Reshape Biotech's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Reshape Biotech's Competitors and alternates

Top competitors of Reshape Biotech include Automata, Opentrons and Transcriptic. Here is the list of Top 10 competitors of Reshape Biotech, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Automata
Automata
2015, London (United Kingdom), Series C
Developer of modular lab automation platforms for biological research workflows
$177M
67/100
2nd
Logo for Opentrons
Opentrons
2013, Brooklyn (United States), Series C
Developer of pipetting robot for lab automation
$261M
61/100
3rd
Logo for Transcriptic
Transcriptic
2012, Menlo Park (United States), Series A
Provider of a cloud-based remote robotic bio-lab
$27.7M
54/100
4th
Logo for Medra
Medra
2021, San Francisco (United States), Series A
Developer of robots to automate repetitive wet lab tasks
$63M
49/100
5th
Logo for Reshape Biotech
Reshape Biotech
2018, Kongens Lyngby (Denmark), Series A
Provider of scalable robotic platform
$29.2M
49/100
6th
Logo for MEGAROBO
MEGAROBO
2016, Singapore (Singapore), Series C
Provider of robotic solutions for industrial laboratory automation
$427M
47/100
7th
Logo for Andrew Alliance
Andrew Alliance
2011, Vernier (Switzerland), Acquired
Provider of automated liquid handling tools and software for scientific labs
$14M
45/100
8th
Logo for Chemspeed
Chemspeed
1997, Fullinsdorf (Switzerland), Acquired
Designer and manufacturer of lab instruments and consumables for R&D industries
-
44/100
9th
Logo for Protedyne
Protedyne
2000, Windsor Locks (United States), Acquired
Develops robotic platform for laboratory automation
$22M
43/100
10th
Logo for Flow Robotics
Flow Robotics
2015, Copenhagen (Denmark), Series A
Provider of an AI-based laboratory automation robot system for liquid handling
$17.1M
42/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Reshape Biotech's competitors? Click here to see the top ones

Reshape Biotech's Investments and acquisitions

Reshape Biotech has made no investments or acquisitions yet.

News related to Reshape Biotech

Media has covered Reshape Biotech for 1 event in last 1 year.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Reshape Biotech

Explore our recently published companies
  • Backchat Media - Tauranga based, 2014 founded, Acquired company
  • Growzle - London based, 2025 founded, Unfunded company
  • X-AVA - United States based, 2021 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford